Delivery Order SPE2DR25D2010-SPE2DR26F4ZFW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Eucrisa 2% Ointment in 60-gram units, with a ceiling value of $1,217.66 and an ultimate completion date of December 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,467.27 to AmerisourceBergen Drug Corp for the supply of Eucrisa 2% Ointment (60gm) on December 2, 2025, with completion required by December 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor's corporate office location in Conshohocken, Pennsylvania also serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,657.85 to AmerisourceBergen Drug Corp for Eucrisa 2% Ointment (60 grams) on November 5, 2025, with completion targeted for November 6, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,222.76 to AmerisourceBergen Drug Corp for the supply of Eucrisa 2% Ointment in 60-gram units. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with a completion deadline of December 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $1,956.74 to AmerisourceBergen Drug Corp for Eucrisa 2% Ointment (60gm), with an ultimate completion date of November 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency for the supply of Eucrisa 2% Ointment (60 gm) with a ceiling value of $1,031.86. The contract was awarded on December 10, 2025, with an ultimate completion date of December 11, 2025, under firm fixed-price terms with no set-aside designation. This delivery order was issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of EUCRISA 2% Ointment in 60-gram units under a firm fixed-price contract with a ceiling value of $4,106.07. The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $4,275.96 delivery order to AmerisourceBergen Drug Corp for EUCRISA 2% Ointment (60GM) on December 2, 2025, with completion scheduled for December 3, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA 19428. This delivery order...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company, to provide a specialty branded pharmaceutical product - Eucrisa 2% Ointment 60GM. The award, valued at $7,349.06, has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eucrisa 2% ointment. The contract has a ceiling value of $3,364.91 and runs through October 8, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZFWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Eucrisa 2% Ointment in 60-gram units, with a contract ceiling value of $2,227.91. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is set for ultimate completion by December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's significant role as a pharmaceutical supplier to the federal government, particularly through the Defense Logistics Agency's medical supply chain. The award is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements—encompassing specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains—positions the company as a key vendor for supporting Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/10/25 |